Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition.
Open Access
- 1 August 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (2) , 1073-1079
- https://doi.org/10.1172/jci116612
Abstract
Urinary kallikrein excretion (UKE) is decreased in rats with passive Heymann nephritis (PHN), but increases after converting enzyme inhibition (CEI). Although CEI potentiates bradykinin activity, neither the effect of CEI on kallikrein secretion nor the abnormal renal kallikrein metabolism in PHN has been examined previously. To determine the mechanism by which CEI increases UKE, normal rats and PHN received enalapril, 40 mg/kg per d orally for 4 d. UKE was 85% lower in PHN than in normals and increased in both groups after CEI, although UKE in PHN remained significantly less than in normals. Kallikrein mRNA was significantly lower in PHN compared to normals but not in PHN treated with CEI and did not change in normal rats. Renin mRNA was significantly lower in PHN, and was stimulated by CEI only in normals. Renal kallikrein and renin content were not different and were not altered by CEI. Both kallikrein and renin genes appear to be transcriptionally suppressed in rats with PHN and the depressed kallikrein mRNA levels can be reversed by CEI. The modest increase in UKE despite normalization of kallikrein mRNA after CEI suggests that there is also a posttranscriptional defect in synthesis and/or secretion of kallikrein.Keywords
This publication has 22 references indexed in Scilit:
- Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.Hypertension, 1991
- The expression of two kallikrein gene family members in the rat kidneyArchives of Biochemistry and Biophysics, 1990
- B2-kinin receptor like binding in rat glomerular membranesBiochemical and Biophysical Research Communications, 1989
- Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation.Journal of Clinical Investigation, 1987
- Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivoKidney International, 1987
- Renal vasoconstrictive effect of kinins mediated by B1-kinin receptorsEuropean Journal of Pharmacology, 1986
- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.Journal of Clinical Investigation, 1986
- Effect of glandular kallikrein on renin release in isolated rat glomeruli.Hypertension, 1985
- Angiotensin Converting Enzyme (ACE) InhibitorsAnnual Review of Pharmacology and Toxicology, 1982
- Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of reninNature, 1978